IN2014KN01142A - - Google Patents

Info

Publication number
IN2014KN01142A
IN2014KN01142A IN1142KON2014A IN2014KN01142A IN 2014KN01142 A IN2014KN01142 A IN 2014KN01142A IN 1142KON2014 A IN1142KON2014 A IN 1142KON2014A IN 2014KN01142 A IN2014KN01142 A IN 2014KN01142A
Authority
IN
India
Prior art keywords
memantine
baclofen
morbidities
administration
combination
Prior art date
Application number
Other languages
English (en)
Inventor
Péter Kovács
Tamás Kitka
Misnyovszki Melinda Egyed
Balázs Varga
Sándor Farkas
Csilla Mária Horváth
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of IN2014KN01142A publication Critical patent/IN2014KN01142A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1142KON2014 2011-11-07 2012-11-06 IN2014KN01142A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1100615A HU230263B1 (hu) 2011-11-07 2011-11-07 Memantin és baclofen hatóanyagokat tartalmazó kombinációs készítmény
PCT/HU2012/000119 WO2013068774A1 (en) 2011-11-07 2012-11-06 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them

Publications (1)

Publication Number Publication Date
IN2014KN01142A true IN2014KN01142A (da) 2015-10-16

Family

ID=89990495

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1142KON2014 IN2014KN01142A (da) 2011-11-07 2012-11-06

Country Status (22)

Country Link
US (1) US20140316007A1 (da)
EP (1) EP2776019A1 (da)
JP (1) JP2014532752A (da)
KR (1) KR20140090203A (da)
CN (1) CN103930099A (da)
AU (1) AU2012335358A1 (da)
BR (1) BR112014010892A2 (da)
CA (1) CA2853872A1 (da)
CL (1) CL2014001167A1 (da)
CO (1) CO6970599A2 (da)
CR (1) CR20140264A (da)
CU (1) CU20140052A7 (da)
EA (1) EA201490935A1 (da)
HK (1) HK1200101A1 (da)
HU (1) HU230263B1 (da)
IL (1) IL232232A0 (da)
IN (1) IN2014KN01142A (da)
MX (1) MX2014005499A (da)
NI (1) NI201400039A (da)
PE (1) PE20141576A1 (da)
SG (1) SG11201401693UA (da)
WO (1) WO2013068774A1 (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040102525A1 (en) * 2002-05-22 2004-05-27 Kozachuk Walter E. Compositions and methods of treating neurological disease and providing neuroprotection
CN101500610A (zh) * 2006-08-11 2009-08-05 国立大学法人名古屋大学 抗肥胖药及其利用
WO2008018275A1 (fr) * 2006-08-11 2008-02-14 National University Corporation Nagoya University Agent anti-obésité et son utilisation

Also Published As

Publication number Publication date
KR20140090203A (ko) 2014-07-16
SG11201401693UA (en) 2014-05-29
WO2013068774A1 (en) 2013-05-16
EP2776019A1 (en) 2014-09-17
CA2853872A1 (en) 2013-05-16
IL232232A0 (en) 2014-06-30
US20140316007A1 (en) 2014-10-23
CL2014001167A1 (es) 2014-07-04
CR20140264A (es) 2014-07-11
HU230263B1 (hu) 2015-11-30
HUP1100615A2 (en) 2013-06-28
CU20140052A7 (es) 2014-07-30
NI201400039A (es) 2014-10-02
EA201490935A1 (ru) 2014-08-29
MX2014005499A (es) 2015-02-20
CN103930099A (zh) 2014-07-16
AU2012335358A1 (en) 2014-05-29
JP2014532752A (ja) 2014-12-08
HK1200101A1 (en) 2015-07-31
PE20141576A1 (es) 2014-11-06
BR112014010892A2 (pt) 2017-06-13
CO6970599A2 (es) 2014-06-13

Similar Documents

Publication Publication Date Title
MX2019000586A (es) Virus adenoasociados (aav) sflt-1 para usarse en el tratamiento de degeneración macular relacionada con la edad (amd).
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
MX2019006739A (es) Esteroides neuroactivos sustituidos con 19-alcoxi-17, profarmacos de los mismos, y metodos de tratamiento usando los mismos.
GB201118656D0 (en) New compounds
TN2013000310A1 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
MY183534A (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MY163031A (en) Method of treating obesity using antioxidant inflammation modulators
GB2491775A (en) Pulsatile drug release
MX2014015423A (es) Analogos de peptido de exedina-4.
MY169328A (en) Compositions for the treatment of dry eye
MX354988B (es) Formulaciones de anticuerpo y metodos.
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
TN2013000239A1 (en) New form of administration of enkephalinase inhibitor
MX2013001267A (es) ANTICUERPOS A IL-1ß E EIL-18 PARA TRATAMIENTO DE ENFERMEDAD.
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
MX2014002394A (es) Inhibidores de rock suaves, novedosos.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
MX347541B (es) Analogos de acido sialico.
MX356317B (es) Tratamiento de síntomas asociados a gastroparesia femenina.
MX2013015419A (es) Dha y epa en la reduccion de estres oxidante.
IN2014DN03010A (da)
WO2013163562A3 (en) Compositions and methods for treating ptsd and related diseases
AU2012307449A8 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
PH12015501211A1 (en) Use of pidotimod to treat atopic dermatitis